PRJNA772730
The FOUNDATION Study: Hospital Formulation Of B. infantis EVC001 Utilized In The NICU  To Demonstrate Tolerability In Our Preterm Neonates
The proposed clinical study will evaluate the tolerability of feeding preterm infants a B. infantis probiotic (EVC001) as the primary endpoint. This particular strain of Bifidobacterium has been shown to uniquely utilize oligosaccharides found in human breast milk, possibly providing a nutritional benefit for the infant consuming breast milk when B. infantis is colonized in the gut.